During the past decade, Cancer Research UK and University College London Cancer Trials Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Cancer Research UK" with 2 trials sponsored, "University College, London" with 2 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research UK and University College London Cancer Trials Centre" are "Lymphoma" (2 trials), "Metastatic Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced Ovarian Cancer" (1 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Cancer Research UK and University College London Cancer Trials Centre" in a lesser frequency.

Most popular intervention types in "Cancer Research UK and University College London Cancer Trials Centre" are "Drug" (10 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "carboplatin" (2 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research UK and University College London Cancer Trials Centre" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Research UK and University College London Cancer Trials Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cancer Research UK and University College London Cancer Trials Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research UK and University College London Cancer Trials Centre, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".